LSV Asset Management has increased its ownership in biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) by 1.7%. The firm acquired an additional 138,119 shares, bringing its total holding to 8,269,472 shares. This strategic move positions BMY as LSV's 22nd largest holding, with an estimated value of $372.95 million. The increased stake follows Bristol Myers Squibb's recent Q4 earnings report, which saw an EPS of $1.26, a revenue beat of $12.5 billion, and a raised quarterly dividend to $0.63 per share. Despite the mixed earnings, LSV's action signals continued confidence in the pharmaceutical company.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis